ArticleClinical and molecular hepatology2026

Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangitis: Letter to the editor on "Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial".

Yizi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.